New magnetically controlled thrombolytic successfully passed preclinical testing

New anti-thrombosis drug based on magnetite nanoparticles developed at ITMO University was successfully tested on animals. Preclinical studies showed drug's high efficacy and safety. Clot dissolution time of the new drug is 20 times shorter than the one of traditional medications. The range of permissible concentrations is very high, and the minimum dose of the active substance was a hundred times smaller than usual. The results are published in Applied Materials and Interfaces.